Therapeutic effects of Lentinan in gastrointestinal inflammation and carcinogenesis – A scoping review of evidence from preclinical and clinical studies
Jennifer S Scholz, Stefan Bereswill, Markus M Heimesaat · 2026
Read Therapeutic effects of Lentinan in gastrointestinal inflammation and carcinogenesis – A scoping review of evidence from preclinical and clinical studies by Jennifer S Scholz, Stefan Bereswill, Markus M Heimesaat (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617346.txt.
Description
Jennifer S Scholz and coauthors reviewed evidence on lentinan, a sugar compound drawn from shiitake mushrooms, for gut inflammation and gut cancer in a 2026 scoping review. Lentinan is used as an add-on cancer treatment in parts of Asia. It is credited with antioxidant and anti-tumor effects. Yet how it works and how best to use it remain unclear. The authors gathered preclinical and clinical studies on its effects in the gut and beyond.
Across studies, lentinan protected against colitis, gut injury from chemotherapy or immune suppression, infection models, and colorectal tumor growth. It acted through the gut lining, immune signaling, and gut microbes. It also interfered with cell death, self-cleaning, stem-like behavior, and blood vessel growth. It appeared to boost chemotherapy and CAR-T cell therapy while easing side effects and improving survival and well-being. Effects depended on size, dose, and route.
Catalog record
| CREATOR | Jennifer S Scholz, Stefan Bereswill, Markus M Heimesaat |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 123 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |